On November 5, the leading personal care and cosmetic ingredient event in Asia Pacific (In-Cosmetics Asia) grandly opened in Bangkok, Thailand. The 2024 edition has attracted over 600 of the most innovative raw material suppliers and finished product manufacturers from more than 30 countries worldwide. During the ceremony, Dr. Ruiyan Wang, General Manager of the Raw Material R&D Centre at Bloomage, was awarded one of the 9 Faces of the APAC Beauty Industry 2024 in recognition of her revolutionary contributions and achievements.
In-Cosmetics Asia established the 9 Faces of the APAC Beauty Industry 2024 award to honour industry leaders in the APAC region who lead innovation and make outstanding achievements in the cosmetics and personal care industry. The award's judging criteria include a significant milestone achievement, a new product that fills a gap in the market, a considerable contribution to education within the industry, and a dedication to significantly improving product sustainability. Dr. Ruiyan Wang's award is not only a personal recognition but also a high affirmation of Bloomage's continuous innovation and contribution to the cosmetics and personal care industry.
As a company that continually embraces the development logic of "Science → Technology → Product → Brand", Bloomage firmly understands the importance of technological innovation. To coordinate and strengthen the aggregation capacity of innovative resources, effectively enhancing the level of technology transfer and industrialization, Bloomage has developed and refined a research and development innovation platform primarily composed of one national enterprise technology centre, two core research areas, six high-end scientific research platforms, and eight research laboratory bases. On this robust innovation platform, many outstanding research experts have emerged, and Dr. Ruiyan Wang is one of the best.
Dr. Ruiyan Wang graduated from the School of Life Sciences at Tsinghua University and has been focusing on the research of cutting-edge technologies in the life and health industry since her graduation. She currently serves as the General Manager of the Raw Material R&D Centre at Bloomage, and she is fully responsible for managing the research and development of bioactive materials. Under her leadership, the team has successfully established a comprehensive and leading R&D platform and launched several innovative products, including recombinant human III collagen, ultrapure ergothioneine, ectoin, zinc hyaluronate, lipopeptide, PDRN, etc. With excellent performance and quality, these products have received widespread recognition from clients and consumers and enhanced Bloomage's good reputation and brand image in the industry.
In the future, guided by technological innovation, Bloomage will continue to increase investment in R&D and adhere to independent innovation. The company will leverage biomanufacturing technologies to create more biomaterials and innovative products that provide consumers with safer, more effective, and environmentally friendly personal care solutions. Meanwhile, Bloomage will further improve talent cultivation and acquisition, fully capitalizing on its advantages in innovation platforms, resource allocation, talent aggregation, and technological foundations, empowering people with healthy, beautiful, and joyful life experiences through biotechnology.
